Relugolix Recruiting Phase 3 Trials for Prostate Cancer Treatment

IndicationsStatusPurposePhase
RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT03085095A Study to Evaluate the Safety and Efficacy of Relugolix in Men With Advanced Prostate Cancer